Search Results
Aug 05, 2025, 10:45 ET Liquid Biopsy Market worth US$7.05 billion by 2030 with 11.8% CAGR | MarketsandMarkets™
the liquid biopsy market is segmented by technology into multi-gene parallel analysis using NGS and single-gene analysis using PCR & microarrays. In 2024, the multi-gene parallel analysis using NGS segment accounted for the largest share of the market. The large share of this segment is attributed
More news about: MarketsandMarkets
Aug 04, 2025, 14:07 ET Microbiome Sequencing Market on the Rise: 19.3% CAGR Forecast
resources that accelerate market growth. Advances in Sequencing Technology: Technological improvements such as next-generation sequencing (NGS) and long-read platforms have enhanced the speed, accuracy, and depth of microbiome analysis. These advances make sequencing more efficient and valuable
More news about: BCC Research LLC
Jul 31, 2025, 16:30 ET ePlus Announces First Quarter Fiscal Year 2026 Earnings Release Date and Conference Call
HERNDON, Va., July 31, 2025 /PRNewswire/ -- ePlus inc. (NASDAQ NGS: PLUS –
More news about: EPLUS INC.
Jul 31, 2025, 14:38 ET Global Oncology Diagnostics Market to Reach $101.5 Billion by 2029
eosin (H&E) staining, Immunohistochemistry (IHC), in situ hybridization (ISH), polymerase chain reaction (PCR), and next generation sequencing (NGS).Which technology segment will be dominant through 2029?- Diagnostic
More news about: BCC Research LLC
Jul 31, 2025, 09:00 ET Sequentify Appoints Dr. Ravi Majeti as Scientific Advisor
beyond." Dr. Majeti's deep scientific insight and clinical perspective will be instrumental as Sequentify expands its portfolio of hematology-focused NGS panels and drives adoption across academic and clinical settings. About Sequentify: Founded in 2021 as a Weizmann Institute spinoff,
More news about: Sequentify ltd.
Jul 31, 2025, 07:00 ET Rice Biotech Launch Pad welcomes Carolyn Ng to external advisory board
doctorate in cancer molecular biology from the National University of Singapore, where she was also awarded the prestigious NGS Integrative Sciences and Technology PhD scholarship. Ng is the 16th member of the Launch Pad's external advisory board. The other members are
More news about: Rice University
Jul 29, 2025, 10:15 ET Molecular Diagnostics Market to Hit USD 33.7 Billion by 2032, Growing at 7.3% CAGR | SkyQuest Technology Consulting
toward tailored treatment plans based on individual genetic profiles. Technological advancements such as real-time PCR, next-generation sequencing (NGS), and microarray technology have significantly improved the speed, sensitivity, and specificity of molecular tests, further fueling their clinical adoption.
More news about: SkyQuest Technology
Jul 29, 2025, 07:00 ET Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU
also provides our biopharma partners with a reliable, regulatory-ready solution to de-risk multiyear clinical trial strategies, ensuring continuity in NGS testing for trials that will extend beyond the IVDR transition timelines." PGDx elio tissue complete makes it easier for laboratories to bring
More news about: Labcorp
Jul 24, 2025, 07:00 ET Fapon at ADLM 2025: One-stop IVD Solutions & Deepened US Commitment
and control for the rheumatoid factor (RF) assay. In molecular diagnostics, Fapon provides solutions for qPCR/RT-qPCR, isothermal amplification, and NGS library preparation, featuring products like ProPrime Taq DNA polymerase and NextGen universal FS DNA library prep kit. It is worth mentioned that Fapon's
More news about: Fapon
Jul 22, 2025, 08:30 ET Caris Life Sciences Validates and Extends Findings on Tumor-Infiltrating Clonal Hematopoiesis
biology, ultimately leading to better outcomes for patients." Caris built on the findings from the study and analyzed 3,255 matched tumor–blood NGS samples from its extensive real-world clinico-genomic database of over 500,000 samples. The study focused on patients with late-stage cancer and confirmed
More news about: Caris Life Sciences
Jul 17, 2025, 21:30 ET EFGH Expands Presence in Africa
confidence in our trajectory for accelerated expansion." Wilf Blackburn, Chairman of the Global Advisory Board, echoed Ng's sentiments, emphasising, "EFGH is rapidly expanding its presence in Africa, a continent characterised by exciting demographics.
More news about: Embed Financial Group Holdings
Jul 17, 2025, 02:30 ET One Biosciences Announces €15 Million Series A Financing to Advance Clinical Single Cell Profiling
Publique - Hôpitaux de Paris AP-HP, Pitié-Salpêtrière and Paris Brain Institute, said: "Widespread use of next generation sequencing (NGS) profiling has led to substantial advances in cancer care but the clinical benefit remains limited to small patient subsets. We believe clinical grade
More news about: One Biosciences
Jul 15, 2025, 09:00 ET Bain & Company forms strategic partnership with Dr. Andrew Ng to accelerate AI transformation for clients worldwide
The collaboration combines Bain's deep industry knowledge and expertise in AI implementation with Dr. Ng's pioneering insights in AI and machine learning, with the goal of empowering companies to move beyond experimentation and deliver enterprise-level results
More news about: Bain & Company
Jul 14, 2025, 03:00 ET Bridge Capture™ 在結直腸癌試點中實現靈敏兼可擴展的液體活檢
Geno1® 技術的體現，而該等技術是基於環狀 DNA 和線性 DNA 擴增。技術總監兼該技術的發明者 Juha-Pekka Pursiheimo 補充：「Bridge Capture 透過使用環狀單股 DNA，為 NGS 庫設計建立新標準——較傳統線性庫更靈活兼更強大的替代方案。結合我們的無 PCR DNA 擴增方法，為 Genomill 徹底改變 NGS 庫製備作定位。 」 該完整研究（標題為「Bridge Capture 技術在轉移性結直腸癌患者液體活檢突變分析的評估 」）現載於《科學報告》網站 （連結
More news about: Genomill Health
Jul 14, 2025, 03:00 ET Bridge Capture™ enables sensitive, scalable liquid biopsy in colorectal cancer pilot
Capture establishes a new standard for NGS library design by using circular single-stranded DNA - a more flexible and robust alternative to traditional linear libraries. Together with our PCR-free DNA amplification approaches, this positions Genomill to revolutionize NGS library preparation." The full
More news about: Genomill Health
Jul 14, 2025, 03:00 ET Bridge Capture™ enables sensitive, scalable liquid biopsy in colorectal cancer pilot
Capture establishes a new standard for NGS library design by using circular single-stranded DNA - a more flexible and robust alternative to traditional linear libraries. Together with our PCR-free DNA amplification approaches, this positions Genomill to revolutionize NGS library preparation." The full
More news about: Genomill Health
Jul 14, 2025, 03:00 ET Bridge Capture™ ermöglicht empfindliche, skalierbare Flüssigbiopsie in Darmkrebs-Pilotprojekten
für das Design von NGS-Bibliotheken, indem es zirkuläre einzelsträngige DNA verwendet – eine flexiblere und robustere Alternative zu herkömmlichen linearen Bibliotheken. Zusammen mit unseren PCR-freien DNA-Amplifikationsansätzen ist Genomill damit in der Lage, die Vorbereitung von NGS-Bibliotheken zu revolutionieren."
More news about: Genomill Health
Jul 14, 2025, 03:00 ET Bridge Capture™, 대장암 액체 생검 파일럿 연구에서 확장 가능한 고감도 분석 기술 입증
푸르시헤이모(Juha-Pekka Pursiheimo) 기술 개발자이자 최고기술책임자(CTO)는 "Bridge Capture는 기존 선형 라이브러리에 비해 훨씬 유연하고 강력한 대안인 원형 단일 가닥 DNA를 사용하여 NGS 라이브러리 설계의 새로운 기준을 제시한다. 당사의 PCR-free DNA 증폭 기술과 결합하면, 지노밀은 NGS 라이브러리 전처리 방식에 혁명을 일으킬 수 있다"라고 말했다. 전체 논문은 '전이성 대장암 환자의 액체 생검을 활용한 돌연변이 프로파일링을 위한 Bridge Capture 기술 평가(Bridge Capture)'라는
More news about: Genomill Health
Jul 14, 2025, 03:00 ET Bridge Capture™ permite realizar biopsias líquidas sensibles y escalables en pruebas piloto de cáncer colorrectal
diseño de bibliotecas NGS al usar ADN circular monocatenario, una alternativa más flexible y sólida a las bibliotecas lineales tradicionales. Junto con nuestros enfoques de amplificación de ADN sin PCR, esto posiciona a Genomill para revolucionar la preparación de la biblioteca NGS". El estudio completo,
More news about: Genomill Health
Jul 14, 2025, 03:00 ET Bridge Capture™ possibilita biópsia líquida sensível e escalável em um estudo piloto sobre câncer colorretal
design de bibliotecas NGS usando DNA de fita simples circular - uma alternativa mais flexível e robusta às bibliotecas lineares tradicionais. Juntamente com nossas abordagens de amplificação de DNA sem PCR, isso permite que a Genomill revolucione a preparação da biblioteca NGS." O estudo completo,
More news about: Genomill Health
Jul 14, 2025, 03:00 ET Bridge Capture™ permet une biopsie liquide sensible et évolutive dans le cadre d'un projet pilote sur le cancer colorectal
(ddPCR), la référence dans ce domaine, tout en offrant une évolutivité illimitée du panel et un flux de travail simple et rentable qui permet des essais NGS décentralisés.
More news about: Genomill Health
Jul 14, 2025, 03:00 ET Bridge Capture™ permite una biopsia líquida sensible y escalable en un proyecto piloto de cáncer colorrectal
de bibliotecas NGS mediante el uso de ADN circular monocatenario, una alternativa más flexible y robusta a las bibliotecas lineales tradicionales. Junto con nuestros métodos de amplificación de ADN sin PCR, esto posiciona a Genomill para revolucionar la preparación de bibliotecas NGS". El estudio
More news about: Genomill Health
Jul 14, 2025, 02:39 ET n6™ Announces Strategic Partnership with SeqCenter to Deliver Unmatched Data Quality in Metagenomics
profiling accessible to all researchers.A Partnership for All NGS WorkflowsThe n6 and SeqCenter collaboration is not limited to full-length 16S sequencing. Any next-generation sequencing (NGS) workflow where data quality is paramount can benefit from iconPCR's transformative
More news about: n6
Jul 11, 2025, 06:12 ET June in Review: 14 Top Health Press Releases
SomaLogic in December 2021 to bring the SomaScan® Proteomics Assay onto Illumina's high-throughput next-generation-sequencing (NGS) platforms.
More news about: PR Newswire
Jul 10, 2025, 08:29 ET Cellecta, Inc. Expands Immune Profiling Portfolio with DriverMap™ Single-Cell AIR Kits for Affordable, High-Resolution Chain-Pairing of T-Cell and B-Cell Receptors
or budgetary constraints." Optimized for use on Illumina next-generation sequencing (NGS) platforms, the DriverMap scAIR kits integrate seamlessly into standard laboratory workflows. These kits generate NGS-ready libraries containing Cellecta's proprietary validator barcodes, which allow for quantitation
More news about: Cellecta Inc.